Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro
Cloning and pharmacological characterization of the dog cannabinoid CB₂receptor.
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
CB2 receptors as new therapeutic targets for liver diseases.
Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Cannabinoid type 2 receptor as a target for chronic – pain.
CB2 receptor-mediated migration of immune cells: it can go either way.
Functional selectivity in CB(2) cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB(2) ligands.